Helmuth van Es(Netherlands · ♂)— A serial Dutch biotech entrepreneur who co-founded multiple drug companies, he spun Citryll out of ModiQuest's tACPA patents in 2015 to develop antibodies targeting neutrophil extracellular traps, serving as CEO.
Renato Chirivi(Italy · ♂)— An immunology researcher and co-inventor of the tACPA antibody technology at ModiQuest, he co-founded Citryll as CSO to turn his NET-targeting science into therapies.
In the network
Shares the most investors with (number = shared investors):